KHAN Technology Transfer Fund
VC Firm•Series A/B • Germany
KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I) is an early-stage life sciences venture fund with €70 million under management. Their mission is to create value through cooperative drug development partnerships with academic innovators in Europe. KHAN-I focuses on first-in-class therapies for attractive markets with a high unmet medical need.
Investment Areas
Typical Investment
€100k-€1.5M
Funding Stage
Series A/B
Headquarters
Germany